National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
HHS-NIH11
POSTED: 12/14/2022
UPDATED: 12/14/2022
DUE: 05/07/2026
Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may ad...
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
HHS-NIH11
POSTED: 12/13/2024
UPDATED: 03/14/2025
DUE: 05/08/2027
The purpose of this initiative is to advance the science of minority health and health disparities by supporting research on family health and well-being and resilience. The NIMHD Research Framework r...
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 12/13/2024
UPDATED: 12/13/2024
DUE: 09/10/2027
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support extramural research to investigate and mitigate challenges facing clinical assay development a...
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 12/13/2024
UPDATED: 04/22/2025
DUE: 09/25/2026
The specific purpose of this Notice of Funding Opportunity (NOFO) is to promote the development of a diverse, interdisciplinary workforce needed to conduct translational research on Alzheimer's diseas...
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 05/21/2025
DUE: 01/11/2026
This Notice of Funding Opportunity (NOFO) supports applications to develop and implement investigator-initiated single site clinical trials including efficacy, comparative effectiveness, pragmatic and...
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 03/31/2025
DUE: 10/19/2026
The purpose of this NOFO is to enhance the capability of NCATS CTSA Program KL2 scholars and recipients of re-entry supplements supported by the CTSA Program to conduct research as they complete the t...
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 12/11/2024
DUE: 07/16/2026
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for pilot projects to identify new druggable targets for pain within the understudied druggable proteome. Awards wil...
High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 12/11/2024
DUE: 10/15/2027
The purpose of the High Impact, Interdisciplinary Science grants program is to support high impact ideas that may lay the foundation for new fields of investigation within the mission of NIDDK. The in...
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 12/11/2024
DUE: 01/07/2028
Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant ...
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 05/21/2025
DUE: 01/11/2026
This Notice of Funding Opportunity (NOFO) supports applications to develop and implement a Clinical Coordinating Center (CCC) for investigator-initiated multi-site clinical trials including efficacy, ...